We revolutionize cancer diagnostics with cutting-edge technology designed to provide personalized, precise, and efficient insights into cancer treatment responses.

About
Vega BioImaging

Resulting from university research, Vega BioImaging was founded to tackle a critical issue in cancer diagnostics: the high rate of companion diagnostic errors (ranging from 7% to 30% depending on the pathology). These errors, driven by a lack of quantitativity, often lead to sub-optimal cancer treatment prescriptions.
By partnering with healthcare providers and pharmaceutical companies, we aim to enhance patient outcomes and accelerate drug development, delivering tailored treatment strategies that improve survival rates while reducing costs for the healthcare system.
Mission

Our mission is to increase the accuracy of cancer diagnostics to ensure that every patient receives the most appropriate treatment, improving their chances of survival and quality of life during therapy.